NEW YORK, Jan. 29, 2018 -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against AMC Entertainment, Inc. (“AMC” or the “Company”) (NYSE:AMC) on behalf of investors that acquired AMC securities in the February 8, 2017 Secondary Public Offering (“SPO”) or during the period from December 20, 2016 through August 1, 2017 (the “Class Period”), inclusive.
Investors who have incurred losses in AMC Entertainment, Inc. are urged to contact the firm immediately at [email protected] or (800) 575-0735 or (212) 545-4774. You may obtain additional information concerning the action on our website, www.whafh.com.
If you have incurred losses in the shares of AMC Entertainment, Inc. and would like to assist with the litigation process as a lead plaintiff, you may, no later than March 13, 2018, request that the Court appoint you lead plaintiff of the proposed class. Please contact Wolf Haldenstein to learn more about your rights as an investor in AMC Entertainment, Inc.
On November 30, 2016, AMC acquired Odeon and UCI Cinemas Holdings, and on December 21, 2016, AMC acquired Carmike Cinemas. Subsequently, on December 21, 2016, AMC filed a shelf Registration Statement with the Securities and Exchange Commission (SEC) to permit the Company to offer and sell AMC common shares. The filed Complaint alleges that throughout the Class Period, Defendants failed to disclose that Carmike’s operations had been performing poorly.
On August 1, 2017, after the close of regular trading, AMC announced worse-than-expected preliminary second quarter 2017 financial results due to a loss of market share that occurred during 2016 and the poor performance of the recently acquired Carmike theaters.
On this news, AMC stock fell from $20.80 to close at $15.20 on August 2, 2017), or more than 50% below the $31.50 per shares price at which the shares were sold in the Secondary Public Offering on February 7, 2017.
Wolf Haldenstein Adler Freeman & Herz LLP has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas; and offices in New York, Chicago and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.
If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735, via e-mail at [email protected], or visit our website at www.whafh.com.
## Follow the firm and learn about newly filed cases on Twitter and Facebook. ##
Contact:
Wolf Haldenstein Adler Freeman & Herz LLP
Kevin Cooper, Esq.
Gregory Stone, Director of Case and Financial Analysis
Email: [email protected], [email protected] or [email protected]
Tel: (800) 575-0735 or (212) 545-4774
Attorney Advertising. Prior results do not guarantee or predict a similar outcome.


Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Washington Post Publisher Will Lewis Steps Down After Layoffs
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



